Trials / Completed
CompletedNCT01304134
Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment
A Prospective, Randomized, Blind, Multicentre, Parallel Group Study to Investigate the Efficacy and Safety of Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA) in the pain relieving treatment during 48h postoperative period, by comparing with morphine i.v. PCA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | dosage:10mg/l dosage form:injection frequency:via PCA pump, background rate:0.5ml/h, 2ml/time duration:48 hours |
| DRUG | Morphine | dosage: 10mg/ml dosage form: injection frequency: via PCA pump, background rate: 0.5ml/h, 2ml/times duration: 48 hours |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2011-02-25
- Last updated
- 2015-08-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01304134. Inclusion in this directory is not an endorsement.